Ophthalmology, Retina Specialist · Garden City, NY
NPI
1225063274
Since 2006
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
520 Franklin Ave, Suite L6
Garden City, NY, 11530
Phone (516) 739-5905
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.6M
60,531 services
Medicare patients, 2024
1,636
Average age 76
Drug cost, 2024
$900K
3,886 prescriptions
Company payments, 2025
$359
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Fleckner was code 95004 (test - miscellaneous), 18,603 times for 312 patients. In total Mark Fleckner billed 60,531 services in 57 codes, and Medicare paid $2.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 18,603 | 312 | $3.42 | $64K |
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 17,643 | 78 | $27.28 | $481K |
| 92134 Computerized Ophthalmic Imaging | Office | 5,114 | 1,621 | $36.53 | $187K |
| 92201 Ophthalmological E&M | Office | 4,480 | 1,610 | $23.22 | $104K |
| 99214 Office E&M - Established | Office | 2,061 | 586 | $118.53 | $244K |
| 99213 Office E&M - Established | Office | 1,413 | 418 | $84.96 | $120K |
| 92014 Ophthalmological E&M | Office | 1,254 | 833 | $114.25 | $143K |
| 67028 Intravitreal Injection | Office | 1,042 | 271 | $119.03 | $124K |
| 92235 Angiography | Office | 712 | 549 | $144.90 | $103K |
| 92242 Angiography | Office | 646 | 452 | $263.54 | $170K |
| 92083 Vision, Hearing, and Speech Services | Office | 559 | 552 | $57.87 | $32K |
| 92020 Ophthalmological E&M | Office | 555 | 545 | $26.21 | $15K |
| 93886 Ultrasound - Nonspecific | Office | 470 | 467 | $223.99 | $105K |
| J0178 Injection, aflibercept, 1 mg | Office | 403 | 50 | $656.84 | $265K |
| J9035 Injection, bevacizumab, 10 mg | Office | 394 | 142 | $56.63 | $22K |
By year: 2022 $1.7M for 23,820 services; 2023 $2.0M for 35,456 services; 2024 $2.6M for 60,531 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark Fleckner prescribed most often to Medicare patients was Azelastine Hcl, with 755 prescriptions and refills. In total Mark Fleckner wrote 3,886 Medicare prescriptions that cost $900K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 755 | 902 | 397 | $14K |
| Diclofenac Sodium Generic | 552 | 761 | 145 | $6,994 |
| Latanoprost Generic | 480 | 1,172 | 157 | $5,302 |
| Bromfenac Sodium Generic | 259 | 327 | 61 | $43K |
| Prednisolone Acetate Generic | 239 | 405 | 137 | $13K |
| Ketorolac Tromethamine Generic | 210 | 312 | 67 | $9,048 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 159 | 324 | 52 | $2,512 |
| Brimonidine Tartrate Generic | 155 | 349 | 54 | $17K |
| Vabysmo Faricimab-Svoa | 107 | 108 | 27 | $308K |
| Eylea Aflibercept | 96 | 96 | 35 | $257K |
| Timolol Maleate Generic | 86 | 172 | 25 | $1,445 |
| Dorzolamide Hcl Generic | 80 | 156 | 24 | $922 |
| Lumigan Bimatoprost | 65 | 126 | 16 | $32K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 56 | 57 | 41 | $643 |
| Simbrinza Brinzolamide/Brimonidine Tart | 45 | 88 | 19 | $14K |
Brand drugs: 1,115 claims; generic drugs: 2,771 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Fleckner $359 ($359 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $77.62.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.